NOVERATECH: OUR UNIQUE NEW PRODUCT

As a startup biotech company, we put tremendous attention to scientific rigor and integrity in our research and development. We are the first to apply intracellular energy delivery for wound care, and we are the first to show that under certain conditions, the traditional 3-6 days of lag time in acute wound healing can be shortened or eliminated in animal experiments.

At this time, our focus is on the mechanisms by which intracellular energy delivery enhances wound healing. At the same time, a critical toxicity study is being performed in order to prepare for IND application to the FDA. We are collaborating with national and international drug/phospholipid companies to continuously improve the formulation to make it easier to use and more effective.    

Need more information?

Check out the information in this section and have a look at our services.